Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia
Condition(s):First Episode SchizophreniaLast Updated:March 17, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):First Episode SchizophreniaLast Updated:March 17, 2014Unknown status
Condition(s):Multiple Sclerosis; Cognitive ImpairmentLast Updated:December 25, 2013Unknown status
Condition(s):DiabetesLast Updated:November 21, 2016Completed
Condition(s):Tobacco Use DisorderLast Updated:March 25, 2019Withdrawn
Condition(s):Coronary Artery Bypass; Cognitive DysfunctionLast Updated:January 11, 2019Unknown status
Condition(s):Amphetamine AddictionLast Updated:January 13, 2020Completed
Condition(s):Tobacco Use DisorderLast Updated:July 2, 2014Completed
Condition(s):Post Traumatic Stress DisorderLast Updated:October 19, 2020Unknown status
Condition(s):ParkinsonLast Updated:May 11, 2023Not yet recruiting
Condition(s):Alzheimer DiseaseLast Updated:March 26, 2012Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.